Saracci R
Unit of Analytical Epidemiology, International Agency for Research on Cancer, Lyons, France.
BMJ. 1991 Oct 12;303(6807):898-900. doi: 10.1136/bmj.303.6807.898.
To improve the validity of comparisons between clinical and postmortem diagnoses when postmortem diagnosis is used to monitor clinical diagnosis performance.
Analysis of elementary examples.
Sensitivity and specificity of clinical and postmortem diagnoses and confirmation and agreement rates. Sensitivity and specificity permit valid comparisons of clinical and postmortem diagnoses among different procedures, sites, or times whereas agreement and confirmation rates may be misleading. Estimates of sensitivity and specificity, however, can be severely distorted by factors such as non-random selection of cases for necropsy or by unrecognised errors in postmortem diagnosis. Such distortion may be minimised by (a) estimating the likely magnitude of errors in postmortem diagnosis, (b) specifying standard conditions for performing necropsies, and (c) ensuring an unbiased sample of moderate size rather than a large biased sample.
Sensitivity and specificity should be used as measures of agreement between clinical and postmortem diagnoses.
Monitoring of clinical diagnosis performance by necropsy surveys requires ensuring accuracy of pathological examinations and validity of study design and analysis.
当使用尸检诊断来监测临床诊断性能时,提高临床诊断与尸检诊断之间比较的有效性。
对基本示例进行分析。
临床诊断和尸检诊断的敏感性和特异性以及确认率和一致率。敏感性和特异性允许在不同程序、部位或时间之间对临床诊断和尸检诊断进行有效比较,而一致率和确认率可能会产生误导。然而,敏感性和特异性的估计可能会因诸如尸检病例的非随机选择或尸检诊断中未被识别的错误等因素而严重失真。通过(a)估计尸检诊断中可能的误差大小,(b)规定进行尸检的标准条件,以及(c)确保一个适度规模的无偏样本而非一个大的有偏样本,可以将这种失真最小化。
敏感性和特异性应用作临床诊断与尸检诊断之间一致性的度量指标。
通过尸检调查监测临床诊断性能需要确保病理检查的准确性以及研究设计和分析的有效性。